Aenco

Active (crowdsale)
Global Healthtech Blockchain Financial Solutions

Whitepaper Project Demo

NOT YET ANALYZED

Sale Ends in

-86Days -23Hours -12Minutes -41Seconds

Pre-Sale: 27 Jul 2018 - 31 Aug 2018
Main Sale: 1 Sep 2018 - 28 Oct 2018

Token Price

1 AEN = 0.1 USD

Symbol
AEN
Platform
Ethereum
Type
ERC20
Decimals
Total Supply
4,000,000,000 AEN
For Sale
600,000,000 AEN
Softcap
15,000,000 USD
Hardcap
60,000,000 USD
Min. Investment
1 ETH
Max. Investment
N/A
Whitelist
YES
KYC
YES
Accepts
ETH, BTC
Incorporated in
Samoa
Restricted in
USA, China
Tokens Distribution
50% Mining Rewards
21% Retained by Company and Team
15% Token Sale (excl. bonus allocations)
14% Bonus Allocations (on token sale) & Incentive Programs
Funds Allocation
40% Sponsorship and Financial Solutions Platform form HealthTech Partners
30% Research, Technology Development and Roll Out, and Collaboration Research
24% General Working Capital and Infrastructure Setup Capital Requirements
3% Marketing and Distribution
3% Legal and Compliance

Aenco is a blockchain based global financial solutions platform, combining decades of experience in traditional financial services and prime brokerage, with network of Healthcare technology (“HealthTech”) innovation partners and new-age applications, collectively developed under the umbrella “Aenco Global HealthTech Financial Solutions platform”.

What is special?

Aenco is the world’s FIRST Blockchain based Healthcare Technology Financial Solutions Platform that leverages healthcare technologies with institutional financing, prime brokerage and smart capital solutions under one umbrella.

Aenco is a “one stop shop” for the delivery of cutting edge institutional financing, prime brokerage and core smart capital solutions for the HealthTech industry, as well as a research and collaboration hub for healthcare companies and projects involved in the field of blockchain development.

Aenco will be combining its solutions platform and core financial ecosystem with the wider healthcare technology community, through the AEN token, as the key ecosystem building block and extensions across ALL its service and community deliveries.

This platform empowers emerging and innovative healthcare companies with digital financing capabilities, so that they can focus on generating high potential and impactful technologies that can transform our world and day to day lives.

It is supported by the group’s planned regulated infrastructure (including the establishment of a commercial bank within the group) and presence in major jurisdictions including Europe, Hong Kong, and the United States, through which Aenco will effectively deliver its solutions, generating an increasing and rapidly evolving ecosystem.

Team Members
Ian Huen
Co-Founder
Darren Lui
Co-Founder
Kenrick Fok
CFO
Geoff Tipy
CTO
Charles Lau
Managing Director
Erica Chan
Head of Wealth Management
Isabella Lai
Senior Director
Teddy Ip
Senior Director
Nick Wan
Co-Investment Director
Calvin Poon
Co-Investment Director
Ally Cheung
Head of Community Management
David Carey
Senior Cloud Engineer
Aaron Regala
Business Analyst
Andy Chan
Head of Insurance
Issac Cheung
Full Stack Developer
Advisors
Douglas W. Arner
Senior Regulatory and Strategic Advisor
Virginia Lam
Marketing Advisor
Douglas Ching
Marketing Advisor
S.M. Yiu
Advisor
Jeff Marquass
Advisor
Albert Leung
Advisor
Kenny Yu
Advisor
Kwok Ka Wai
Advisor
Owen Ko
Advisor
Sunny Wong
Advisor
William Wu
Advisor
Joe Hui
Advisor
Julian Ting
Advisor
Shell Cheung
Advisor
Partners
IDAX
LATOKEN
ENTERPRISE ETHEREUM ALLIANCE
TideBit
NO REST LABS
Identity Mind Global
ECOVIS
SIGNATE
TVM CHINA
Videns Life Sciences
ICO 101
CRYPTO 101
tokenline
Stevensons Lawyers
Bountyhive
tokenmez
  • 2005
    Aeneas Capital grante Asset Management license by SFC (Hong Kong).
  • 2008-2009
    Fund products generate positive returns throughout subprime crisis.
  • 4Q 2010
    Assets managed by Aeneas deployed into health care private equity and direct investments.
  • 2Q 2016
    Aeneas Group builds healthtech partnership with Aptorum Group, a multi-disciplinary medical innovations platform based in HK.
  • 3Q 2017
    Aeneas Capital initiates to expand its licenses with the SFC in HK to include dealing and advising in securities;
    Aeneas expands partnerships with healthtech companies specializing in neuro, infectious diseases, and robotic surgery devices.
  • 1Q 2018
    Aeneas Capital, LLC. established in New Jersey, U.S.A. to set up a FINRA regulated broker dealer (in progress); Aeneas Group establishing a full-service banking license in Europe (in progress).
  • 2Q 2018
    June Initiate Private Sale;
    Aeneas Capital granted expanded licenses by the SFC in HK to deal and advise in securities;
    Community investors outreach.
  • 4Q 2018
    Expand team: Developers;
    1st pipeline healthtech;
    ICO launch;
    Launch first generation smart wallet & infrastucture (AEN Connect).
  • 4Q 2019
    Second generation: AENX trading exchange.
  • 2Q 2020
    Third generation: AENCO prime brokerage platform;
    ngoing service & expansion of pipeline HealthTech partners.
Bonus Details
Sale Commission (Aff/Ref)
%
Bounty Details
Total Budget =
Campaign Share

Product

Data
Result
Product Differentiation
%
Blockchain Utilization
%
Whitepaper Presentation
%
Roadmap
%
MVP/Prototype
%
%

Business

Data
Result
Valuation
%
Market Potential
%
Competition
%
Legal
%
%

Token

Data
Result
Token Usage
%
Smart Contract
%
Fundraising Goals
%
Token Allocation
%
Funds Usage
%
%

Team

Data
Result
Background of Management Team
%
Team LinkedIn Profiles
%
Team KYC
%
Quality of Advisors
%
Quality of Partners
%
%

Community

Data
Result
Size of Community
%
Social Activity
%
Marketing
%
Support
%
%
0
Rating
Investor (0 votes) {{ reviewsOverall }} / 5
What investor say... Leave your rating
Order by:

Be the first to leave a review.

User Avatar User Avatar
Verified
{{{ review.rating_title }}}
{{{review.rating_comment | nl2br}}}

Show more
{{ pageNumber+1 }}
Leave your rating